{
    "symbol": "ZENV",
    "quarter": 1,
    "year": 2022,
    "date": "2022-05-08 00:55:05",
    "content": " And that\u2019s why we expect to combine both the R&D investments at this phase of 12% in terms of  And also keep our M&A strategy active so we can move to our second phase of acquisitions that will open our thesis to more possibilities in terms of market consolidation, in terms of international expansion, and also to bring more value as a mission to specific niche markets, although we\u2019re very happy with what we cover indeed, and we, of course, having the use of proceeds of the IPO direct that to consolidate that strategy in its first phase."
}